Needle-Free rotavirus vaccine patch moves to human testing
NCT ID NCT06962904
First seen Mar 07, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This early-stage study tests a new rotavirus vaccine delivered through a small microneedle patch placed on the skin. Researchers want to see if it is safe and triggers an immune response in healthy adults aged 18 to 45. The vaccine is given in three doses over several months, and participants are monitored for side effects and antibody levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROTAVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory Children's Center - Vaccine Research Clinic
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.